Skip to main content

Severe Combined Immunodeficiency clinical trials at UCSD

1 in progress, 0 open to eligible people

Showing trials for
  • Registry Study of Revcovi Treatment in Patients With ADA-SCID

    Sorry, not currently recruiting here

    This registry is conducted in patients with adenosine deaminase severe combined immune deficiency (ADA-SCID) treated with Revcovi™ to collect periodic clinical and biochemical data on safety and dose adjustment.

    San Diego, California and other locations

Last updated: